Sr. Director, Formulation and Drug Product Development
Regeneron Pharmaceuticals
Hunter Chen is a member of the CRS Industry Foresight Council and previously served as the Industry Liaison for the Ocular Delivery Focus Group. He is currently a Sr. Director, Formulation and Drug Product Development at Regeneron Pharmaceuticals, where he contributed to the development of Eylea, Veopoz, and Ordspono. His industry experience includes formulation, delivery technologies, and drug product development for biologics and genetic medicines. He received his PhD in Biomedical Engineering from Johns Hopkins University.
Disclosure information not submitted.
Tuesday, July 15, 2025
2:02 PM - 2:04 PM EDT
YSC & Industry Foresight Council - Chat with Industry
Thursday, July 17, 2025
1:00 PM - 2:00 PM EDT
